As of November 2024, Walvax Biotechnology has a market cap of $2.25B. This makes Walvax Biotechnology the world's 4811th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $4.00B | -25.10% |
2023 | $5.34B | -41.50% |
2022 | $9.12B | -28.49% |
2021 | $12.76B | 45.75% |
2020 | $8.75B | 18.87% |
2019 | $7.36B | 69.84% |
2018 | $4.34B | 4.66% |
2017 | $4.14B | 67.43% |
2016 | $2.47B | -17.30% |
2015 | $2.99B | 95.89% |
2014 | $1.53B | 34.60% |
2013 | $1.13B | 4.39% |
2012 | $1.09B | -1.73% |
2011 | $1.11B | -48.64% |
2010 | $2.15B | - |